<DOC>
	<DOCNO>NCT01185743</DOCNO>
	<brief_summary>Schizophrenia severe chronic disable mental disorder associate significant reduction life expectancy . Atypical antipsychotic treatment compliance may jeopardize drug induce weight gain abnormality carbohydrate lipid metabolism . Aim : gain data drug relate effect gene expression regulation special regard glucose metabolism .</brief_summary>
	<brief_title>Antipsychotics Gene Expression Soft Tissues</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male . Healthy , define absence relevant disease . Caucasian . Aged 1845 year . BodyMassIndex ( BMI ) : 1825 kg/m2 . Signed informed consent . No sign impair glucose tolerance evaluate Oral Glucose Tolerance Test ( OGTT ) study inclusion screening , normal total cholesterol , High Density Lipoprotein ( HDL ) , Low Density Lipoprotein ( LDL ) , triglyceride , normal function thyroid . No personal family history ( parent sibling ) diabetes metabolic relevant disease define investigator . No indication psychiatric disease assess structured clinical interview ( MiniInternational Neuropsychiatric Interview ( MINI ) ) . Personal family history ( parent sibling ) diabetes metabolic disease , relevant disease define investigator . History hypertension , blood pressure &gt; 140/90 screening , cardiovascular disease . Body mass index range &lt; 18 &gt; 25 kg/m . Human immunodeficiency virus ( HIV ) Hepatitis B/C positive virology . Allergy hypersensitivity olanzapine/ziprasidone another excipient . Contraindications use drug accord Summary Product Characteristics ( SmPC ) . Any drug intake 2 week prior first study day . History excessive bleeding tendency/hemophilia . Presence relevant illness within last 3 week . Currently enrol clinical study Investigational Medicinal Products ( IMPs ) . Last study participation le 4 week . Suspected noncompliance study instruction lifestyle requirement . History alcohol drug abuse . Blood/Plasma donation within 4 week prior study day . Previous exposure antipsychotic drug . Nicotine consumption time enrolment ( least 3 month nonsmoking require ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>gene expression</keyword>
</DOC>